Active Ingredient History
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Arthritis, Rheumatoid (Phase 2)
Asthma (Phase 2)
Breast Neoplasms (Phase 2)
Bronchiolitis (Phase 1/Phase 2)
Bronchiolitis Obliterans (Phase 1)
Carcinoma, Hepatocellular (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Renal Cell (Phase 1)
Carcinoma, Transitional Cell (Phase 1)
Chondrosarcoma (Phase 1)
Colitis, Ulcerative (Phase 2)
Colorectal Neoplasms (Phase 1)
Cytokine Release Syndrome (Phase 2)
Endometrial Neoplasms (Phase 1)
Gastrointestinal Neoplasms (Phase 2)
Graft vs Host Disease (Phase 3)
Head and Neck Neoplasms (Phase 1)
Hematologic Neoplasms (Phase 1)
Hematopoietic Stem Cell Transplantation (Phase 2)
Hodgkin Disease (Phase 2)
Leiomyosarcoma (Phase 1)
Leukemia, B-Cell (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 1)
Liposarcoma (Phase 1)
Lung Neoplasms (Phase 1/Phase 2)
Lymphohistiocytosis, Hemophagocytic (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Non-Hodgkin (Phase 1)
Melanoma (Phase 1)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 1/Phase 2)
Polycythemia Vera (Phase 2)
Primary Myelofibrosis (Phase 2)
Pruritus (Phase 2)
Psoriasis (Phase 2)
Sarcoma (Phase 1)
Sarcoma, Synovial (Phase 1)
Scleroderma, Systemic (Phase 2)
Thrombocytosis (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue